DE3815221C2
(de)
*
|
1988-05-04 |
1995-06-29 |
Gradinger F Hermes Pharma |
Verwendung einer Retinol- und/oder Retinsäureester enthaltenden pharmazeutischen Zubereitung zur Inhalation zur Einwirkung auf die Schleimhäute des Tracheo-Bronchialtraktes einschließlich der Lungenalveolen
|
US6681767B1
(en)
*
|
1991-07-02 |
2004-01-27 |
Nektar Therapeutics |
Method and device for delivering aerosolized medicaments
|
KR100246082B1
(ko)
*
|
1991-07-02 |
2000-04-01 |
인헤일, 인코오포레이티드 |
에어로졸화된약제를전달하는방법및장치
|
IT1253711B
(it)
*
|
1991-12-17 |
1995-08-23 |
Alfa Wassermann Spa |
Formulazioni farmaceutiche vaginali contenenti rifaximin e loro uso nel trattamento delle infezioni vaginali
|
DE4203306A1
(de)
*
|
1992-02-06 |
1993-08-12 |
Ig Spruehtechnik Gmbh |
Asthma oder pulmonal-aerosolzubereitungen mit lecithin
|
US6231851B1
(en)
*
|
1994-05-18 |
2001-05-15 |
Inhale Therapeutic Systems |
Methods and compositions for the dry powder formulation of interferons
|
KR100291620B1
(ko)
*
|
1992-09-29 |
2001-10-24 |
추후제출 |
부갑상선호르몬의활성단편의폐를통한전달방법
|
TW252974B
(es)
*
|
1993-03-23 |
1995-08-01 |
Takeda Dharm Industry Co Ltd |
|
US20030113273A1
(en)
*
|
1996-06-17 |
2003-06-19 |
Patton John S. |
Methods and compositions for pulmonary delivery of insulin
|
US6290991B1
(en)
*
|
1994-12-02 |
2001-09-18 |
Quandrant Holdings Cambridge Limited |
Solid dose delivery vehicle and methods of making same
|
US5944012A
(en)
*
|
1996-03-25 |
1999-08-31 |
Pera; Ivo E. |
Method for dispensing antioxidant vitamins by inhalation background of the invention
|
DE19652790A1
(de)
*
|
1996-12-18 |
1998-06-25 |
Hermes Fabrik Pharm Praeparate |
Pharmazeutische Zubereitungen
|
US5998486A
(en)
*
|
1997-07-08 |
1999-12-07 |
Georgetown University School Of Medicine |
Treatment of emphysema with retinoic acid or other retinoids by inducing formation of gas-exchange units (alveoli)
|
US20030035778A1
(en)
*
|
1997-07-14 |
2003-02-20 |
Robert Platz |
Methods and compositions for the dry powder formulation of interferon
|
US20060165606A1
(en)
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
US6309623B1
(en)
*
|
1997-09-29 |
2001-10-30 |
Inhale Therapeutic Systems, Inc. |
Stabilized preparations for use in metered dose inhalers
|
US6565885B1
(en)
|
1997-09-29 |
2003-05-20 |
Inhale Therapeutic Systems, Inc. |
Methods of spray drying pharmaceutical compositions
|
US6703050B1
(en)
*
|
1998-09-04 |
2004-03-09 |
The Regents Of The University Of Michigan |
Methods and compositions for the prevention or treatment of cancer
|
EP1263420B1
(en)
*
|
2000-03-07 |
2005-09-07 |
Battelle Memorial Institute |
Retinoid formulations for aerosolization and inhalation
|
DE10012151A1
(de)
*
|
2000-03-13 |
2001-09-27 |
Gsf Forschungszentrum Umwelt |
Mittel zur Behandlung von Erkrankungen des Tracheo-Brochialtraktes, insbesondere der COPD
|
DE10013093B4
(de)
|
2000-03-17 |
2005-12-22 |
Inamed Gmbh |
Vorrichtung zur kontrollierten Inhalation therapeutischer Aerosole
|
US7871598B1
(en)
|
2000-05-10 |
2011-01-18 |
Novartis Ag |
Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
|
TWI290473B
(en)
|
2000-05-10 |
2007-12-01 |
Alliance Pharma |
Phospholipid-based powders for drug delivery
|
US8404217B2
(en)
|
2000-05-10 |
2013-03-26 |
Novartis Ag |
Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
|
DE10029119B4
(de)
|
2000-06-14 |
2005-12-22 |
Institut für Aerosol Medizin InAMed GmbH |
Inhalationsvorrichtung
|
US6339107B1
(en)
|
2000-08-02 |
2002-01-15 |
Syntex (U.S.A.) Llc |
Methods for treatment of Emphysema using 13-cis retinoic acid
|
EP1935869A1
(en)
|
2000-10-02 |
2008-06-25 |
F. Hoffmann-La Roche Ag |
Retinoids for the treatment of emphysema
|
DE10051858A1
(de)
*
|
2000-10-19 |
2002-06-06 |
Guenther Beisel |
Verwendung von biologisch abbaubaren, substituierten Kohlenwasserstoffen deren Ester, Ether und/oder Amide als Nasensalbe oder Nasentropfen zur Prophylaxe von inhalationsallergischen Reaktionen und zur Pflege der Nasenschleimhaut
|
US6481442B1
(en)
|
2000-11-28 |
2002-11-19 |
Lorillard Licensing Company, Llc |
Smoking article including a filter for selectively removing carbonyls
|
WO2002043514A1
(en)
*
|
2000-11-28 |
2002-06-06 |
Lorillard Licensing Company, Llc |
A smoking article including a selective carbon monoxide pump
|
US20030216471A1
(en)
*
|
2001-03-07 |
2003-11-20 |
Dahl Alan R |
Retinoid formulations for aerosolization and inhalation
|
DE10123749A1
(de)
|
2001-05-16 |
2002-12-12 |
Inamed Gmbh |
Vorrichtung zum Verabreichen von Aerosolen
|
US20030051728A1
(en)
*
|
2001-06-05 |
2003-03-20 |
Lloyd Peter M. |
Method and device for delivering a physiologically active compound
|
US20070122353A1
(en)
|
2001-05-24 |
2007-05-31 |
Hale Ron L |
Drug condensation aerosols and kits
|
US7645442B2
(en)
|
2001-05-24 |
2010-01-12 |
Alexza Pharmaceuticals, Inc. |
Rapid-heating drug delivery article and method of use
|
WO2003026631A1
(en)
*
|
2001-05-24 |
2003-04-03 |
Alexza Molecular Delivery Corporation |
Delivery of drug esters through an inhalation route
|
CA2446904A1
(en)
|
2001-05-24 |
2003-04-03 |
Alexza Molecular Delivery Corporation |
Delivery of drug esters through an inhalation route
|
US7458374B2
(en)
|
2002-05-13 |
2008-12-02 |
Alexza Pharmaceuticals, Inc. |
Method and apparatus for vaporizing a compound
|
US7232924B2
(en)
*
|
2001-06-11 |
2007-06-19 |
Xenoport, Inc. |
Methods for synthesis of acyloxyalkyl derivatives of GABA analogs
|
US7186855B2
(en)
*
|
2001-06-11 |
2007-03-06 |
Xenoport, Inc. |
Prodrugs of GABA analogs, compositions and uses thereof
|
US8048917B2
(en)
|
2005-04-06 |
2011-11-01 |
Xenoport, Inc. |
Prodrugs of GABA analogs, compositions and uses thereof
|
US6818787B2
(en)
*
|
2001-06-11 |
2004-11-16 |
Xenoport, Inc. |
Prodrugs of GABA analogs, compositions and uses thereof
|
HUP0400183A2
(hu)
|
2001-06-11 |
2004-07-28 |
Xenoport Inc. |
Gaba-analóg prodrugok csökkentett toxicitású orális dózisformái
|
DE10137017A1
(de)
*
|
2001-07-30 |
2003-02-20 |
Basf Ag |
Kristallisationsverfahren zur Einstellung kleiner Partikel
|
DE60219677T2
(de)
*
|
2001-10-30 |
2008-05-15 |
Nektar Therapeutics Al, Corp., Huntsville |
Wasserlösliche polymerkonjugate von retinoesäure
|
WO2003053411A1
(en)
|
2001-12-19 |
2003-07-03 |
Nektar Therapeutics |
Pulmonary delivery of aminoglycosides
|
US20040009953A1
(en)
*
|
2002-01-10 |
2004-01-15 |
Comper Wayne D. |
Antimicrobial charged polymers that exhibit resistance to lysosomal degradation during kidney filtration and renal passage, compositions and method of use thereof
|
US20030181416A1
(en)
*
|
2002-01-10 |
2003-09-25 |
Comper Wayne D. |
Antimicrobial charged polymers that exhibit resistance to lysosomal degradation during kidney filtration and renal passage, compositions and method of use thereof
|
US6927036B2
(en)
*
|
2002-02-19 |
2005-08-09 |
Xero Port, Inc. |
Methods for synthesis of prodrugs from 1-acyl-alkyl derivatives and compositions thereof
|
US20030185762A1
(en)
*
|
2002-03-22 |
2003-10-02 |
Cowan Siu Man L. |
Highly aqueous liquid carrier formulations
|
EP1539131A4
(en)
|
2002-07-23 |
2009-07-08 |
Univ Michigan |
TETRAPROPYLAMMONIUM TETRATHIOMOLYBDATE AND ASSOCIATED COMPOUNDS FOR ANTI-ANGIOGENIC THERAPIES
|
US7189865B2
(en)
*
|
2002-07-23 |
2007-03-13 |
Attenuon, Llc |
Thiomolybdate analogues and uses thereof
|
BRPI0313165B8
(pt)
|
2002-08-02 |
2021-05-25 |
Ab Science |
2-(3-aminoaril)amino-4-aril-tiazóis e sua utilização como inibidores de c-kit
|
US8450302B2
(en)
*
|
2002-08-02 |
2013-05-28 |
Ab Science |
2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors
|
AU2003270414A1
(en)
*
|
2002-09-06 |
2004-03-29 |
Oregon Health And Science University |
Effect of vitamin a gel on paranasal sinus mucosal regeneration
|
US20060100167A1
(en)
*
|
2002-09-27 |
2006-05-11 |
Wood Christopher B |
Methods and compositions for the treatment of autoimmune disorders using clofarabine
|
WO2004028463A2
(en)
*
|
2002-09-27 |
2004-04-08 |
Bioenvision, Inc. |
Methods and compositions for the treatment of lupus using clofarabine
|
AU2003282534A1
(en)
*
|
2002-10-07 |
2004-05-04 |
Radiorx, Inc. |
X-nitro compounds, pharmaceutical compositions thereof and uses therof
|
WO2004063213A2
(en)
*
|
2002-11-25 |
2004-07-29 |
Attenuon, Llc |
Peptides which target tumor and endothelial cells, compositions and uses thereof
|
US20040105818A1
(en)
|
2002-11-26 |
2004-06-03 |
Alexza Molecular Delivery Corporation |
Diuretic aerosols and methods of making and using them
|
US7913688B2
(en)
|
2002-11-27 |
2011-03-29 |
Alexza Pharmaceuticals, Inc. |
Inhalation device for producing a drug aerosol
|
AU2003297927A1
(en)
*
|
2002-12-11 |
2004-06-30 |
Xenoport, Inc. |
Prodrugs of fused gaba analogs, pharmaceutical compositions and uses thereof
|
ZA200504940B
(en)
*
|
2003-01-28 |
2006-09-27 |
Xenoport Inc |
Amino acid derived prodrugs of propofol, compositions and uses thereof
|
US7034052B2
(en)
|
2003-03-12 |
2006-04-25 |
Celgene Corporation |
7-Amido-isoindolyl compounds and their pharmaceutical uses
|
PT3889142T
(pt)
|
2003-04-11 |
2022-08-22 |
Ptc Therapeutics Inc |
Compostos de ácido 1,2,4-oxodiazolobenzoico e sua utilização para a supressão sem sentido e o tratamento de doenças
|
CA2526475A1
(en)
|
2003-05-21 |
2004-12-02 |
Alexza Pharmaceuticals, Inc. |
Optically ignited or electrically ignited self-contained heating unit and drug-supply unit employing same
|
MXPA05012722A
(es)
|
2003-05-27 |
2006-05-25 |
Attenuon Llc |
Analogos de tiotungstato y sus usos.
|
US20050009782A1
(en)
*
|
2003-07-09 |
2005-01-13 |
Comper Wayne D. |
Antiviral charged polymers that exhibit resistance to lysosomal degradation during kidney filtration and renal passage, compositions and methods of use thereof
|
US7230003B2
(en)
*
|
2003-09-09 |
2007-06-12 |
Xenoport, Inc. |
Aromatic prodrugs of propofol, compositions and uses thereof
|
NZ545989A
(en)
*
|
2003-09-17 |
2009-10-30 |
Xenoport Inc |
Treating or preventing restless legs syndrome using prodrugs of gaba analogs
|
MXPA06004088A
(es)
*
|
2003-10-14 |
2006-06-27 |
Xenoport Inc |
Forma cristalina de un analogo del acido gamma-aminobutirico.
|
PL1684750T3
(pl)
|
2003-10-23 |
2010-10-29 |
Ab Science |
2-Aminoarylooksazole jako inhibitory kinazy tyrozynowej
|
NZ547689A
(en)
|
2003-11-19 |
2009-05-31 |
Signal Pharm Llc |
Indazole compounds and methods of use thereof as protein kinase inhibitors
|
EP1729784A1
(en)
*
|
2004-02-23 |
2006-12-13 |
Attenuon, LLC |
Formulations of thiomolybdate or thiotungstate compounds and uses thereof
|
US7540286B2
(en)
|
2004-06-03 |
2009-06-02 |
Alexza Pharmaceuticals, Inc. |
Multiple dose condensation aerosol devices and methods of forming condensation aerosols
|
US7241807B2
(en)
*
|
2004-07-12 |
2007-07-10 |
Xenoport, Inc. |
Prodrugs of propofol, compositions and uses thereof
|
WO2006017352A1
(en)
*
|
2004-07-12 |
2006-02-16 |
Xenoport, Inc. |
Amino acid derived prodrugs of propofol, compositions and uses thereof
|
US20060128676A1
(en)
*
|
2004-07-13 |
2006-06-15 |
Pharmacofore, Inc. |
Compositions of nicotinic agonists and therapeutic agents and methods for treating or preventing diseases or pain
|
RU2440112C2
(ru)
|
2004-11-04 |
2012-01-20 |
Ксенопорт, Инк. |
Пероральная дозированная форма габапентина замедленного высвобождения
|
MY176938A
(en)
|
2004-12-17 |
2020-08-27 |
Anadys Pharmaceuticals Inc |
3,5-disubstituted and 3,5,7-trisubstituted-3h-oxazolo and 3h-thiazolo[4,5-d] pyrimidin-2-one compounds and prodrugs thereof
|
CA2586410A1
(en)
*
|
2004-12-23 |
2006-07-06 |
Xenoport, Inc. |
Serine amino acid derived prodrugs of propofol, compositions, uses and crystalline forms thereof
|
WO2006079209A1
(en)
*
|
2005-01-26 |
2006-08-03 |
The University Of British Columbia |
Pulmonary compositions comprising a vitamin a compound and a surfactant and uses thereof
|
CA2596357A1
(en)
|
2005-02-01 |
2006-08-10 |
Attenuon, Llc |
Acid addition salts of ac-phscn-nh2
|
US20080233053A1
(en)
*
|
2005-02-07 |
2008-09-25 |
Pharmalight Inc. |
Method and Device for Ophthalmic Administration of Active Pharmaceutical Ingredients
|
CA2603826C
(en)
|
2005-04-04 |
2013-03-12 |
Ab Science |
Substituted oxazole derivatives and their use as tyrosine kinase inhibitors
|
WO2007013929A1
(en)
|
2005-07-22 |
2007-02-01 |
Amgen Inc. |
Aniline sulfonamide derivatives and their uses
|
US20070135380A1
(en)
|
2005-08-12 |
2007-06-14 |
Radiorx, Inc. |
O-nitro compounds, pharmaceutical compositions thereof and uses thereof
|
US7507842B2
(en)
|
2005-08-12 |
2009-03-24 |
Radiorx, Inc. |
Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof
|
EP2004619A1
(en)
*
|
2006-03-23 |
2008-12-24 |
Amgen Inc. |
1-phenylsulfonyl-diaza heterocyclic amide compounds and their uses as modulators of hydroxsteroid dehydrogenases
|
RU2469038C2
(ru)
|
2006-05-26 |
2012-12-10 |
Фармакофор, Инк. |
Контролируемое высвобождение фенольных опиатов
|
WO2007145834A2
(en)
*
|
2006-06-08 |
2007-12-21 |
Amgen Inc. |
Benzamide derivatives and uses related thereto
|
TW200808695A
(en)
*
|
2006-06-08 |
2008-02-16 |
Amgen Inc |
Benzamide derivatives and uses related thereto
|
BRPI0713680A2
(pt)
|
2006-06-22 |
2012-10-23 |
Anadys Pharmaceuticals Inc |
composto, composição farmacêutica e métodos de modulação das atividades imuno da citocina, de tratamento de infecção de vìrus da hepatite c em paciente e de tratamento de desordem de proliferação relacionada em mamìfero carecido do mesmo
|
JP5306194B2
(ja)
|
2006-06-22 |
2013-10-02 |
アナディス ファーマシューティカルズ インク |
ピロ[1,2−b]ピリダジノン化合物
|
DE602007012881D1
(en)
|
2006-07-18 |
2011-04-14 |
Anadys Pharmaceuticals Inc |
Carbonat- und carbamat-prodrugs von thiazolo ä4,5-dü-pyrimidinen
|
EP2051977A2
(en)
*
|
2006-07-20 |
2009-04-29 |
Amgen Inc. |
SUBSTITUTED AZOLE AROMATIC HETEROCYCLES AS INHIBITORS OF LLbeta-HSD-1
|
CA2663254C
(en)
|
2006-09-15 |
2016-04-19 |
Reviva Pharmaceuticals, Inc. |
Synthesis, methods of using, and compositions of cycloalkylmethylamines
|
EP1905422A1
(en)
*
|
2006-09-28 |
2008-04-02 |
Johnson & Johnson Consumer France SAS |
Stabilized compositons containing retinoids and metal oxide pigments
|
JP2010512328A
(ja)
*
|
2006-12-11 |
2010-04-22 |
レビバ ファーマシューティカルズ,インコーポレーテッド |
インダノン系コリンエステラーゼ阻害薬の組成物、合成および使用方法
|
EP2121580A2
(en)
*
|
2006-12-26 |
2009-11-25 |
Amgen Inc. |
N-cyclohexyl benzamides and benzeneacetamides as inhibitors of 11-beta-hydroxysteroid dehydrogenases
|
US20080216828A1
(en)
|
2007-03-09 |
2008-09-11 |
Alexza Pharmaceuticals, Inc. |
Heating unit for use in a drug delivery device
|
DK2158316T3
(en)
|
2007-05-11 |
2015-07-20 |
Adynxx Inc |
Gene expression and pain
|
NZ582124A
(en)
*
|
2007-05-21 |
2012-07-27 |
Reviva Pharmaceuticals Inc |
Compositions, synthesis, and methods of using quinolinone based atypical antipsychotic agents
|
US9119777B2
(en)
|
2008-05-30 |
2015-09-01 |
Microdose Therapeutx, Inc. |
Methods and compositions for administration of oxybutynin
|
US8415390B2
(en)
|
2008-05-30 |
2013-04-09 |
Microdose Therapeutx, Inc. |
Methods and compositions for administration of oxybutynin
|
US20080306076A1
(en)
*
|
2007-06-08 |
2008-12-11 |
Senomyx, Inc. |
Modulation of chemosensory receptors and ligands associated therewith
|
US7928111B2
(en)
|
2007-06-08 |
2011-04-19 |
Senomyx, Inc. |
Compounds including substituted thienopyrimidinone derivatives as ligands for modulating chemosensory receptors
|
US8633186B2
(en)
|
2007-06-08 |
2014-01-21 |
Senomyx Inc. |
Modulation of chemosensory receptors and ligands associated therewith
|
US9603848B2
(en)
*
|
2007-06-08 |
2017-03-28 |
Senomyx, Inc. |
Modulation of chemosensory receptors and ligands associated therewith
|
CN101778563B
(zh)
|
2007-08-10 |
2014-07-16 |
Vm生物医药公司 |
调节细胞凋亡的组合物和方法
|
EP2116263A1
(en)
|
2008-05-05 |
2009-11-11 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Reversibly light-switchable drug-conjugates
|
WO2009154993A1
(en)
*
|
2008-05-27 |
2009-12-23 |
Reviva Pharmaceuticals, Inc. |
Compositions, synthesis, and methods of using piperazine based antipsychotic agents
|
RU2511315C2
(ru)
|
2008-07-31 |
2014-04-10 |
Синомикс, Инк. |
Композиции, содержащие усилители сладкого вкуса, и способы их получения
|
UA113831C2
(xx)
|
2008-07-31 |
2017-03-27 |
|
Способи і проміжні сполуки для одержання підсилювачів солодкого смаку
|
US20110229438A1
(en)
|
2008-10-09 |
2011-09-22 |
Anadys Pharmaceuticals, Inc. |
Method of inhibiting hepatitus c virus by combination of a 5,6-dihydro-1h-pyridin-2-one and one or more additional antiviral compounds
|
PT2356109T
(pt)
|
2008-10-10 |
2017-03-10 |
Vm Discovery Inc |
Composições e métodos para o tratamento distúrbios de utilização de álcool, dor e outras doenças
|
US9040508B2
(en)
|
2008-12-08 |
2015-05-26 |
Vm Pharma Llc |
Compositions of protein receptor tyrosine kinase inhibitors
|
WO2010099502A1
(en)
|
2009-02-26 |
2010-09-02 |
Reviva Pharmaceuticals, Inc. |
Compositions, synthesis, and methods of utilizing arylpiperazine derivatives
|
WO2011086085A1
(en)
|
2010-01-12 |
2011-07-21 |
Ab Science |
Thiazole and oxazole kinase inhibitors
|
WO2011092273A1
(en)
|
2010-01-28 |
2011-08-04 |
Ab Science |
Treatment of gist with masitinib
|
US8471041B2
(en)
*
|
2010-02-09 |
2013-06-25 |
Alliant Techsystems Inc. |
Methods of synthesizing and isolating N-(bromoacetyl)-3,3-dinitroazetidine and a composition including the same
|
WO2012003501A2
(en)
|
2010-07-02 |
2012-01-05 |
Reviva Pharmaceuticals, Inc. |
Compositions, synthesis, and methods of using cycloalkylmethylamine derivatives
|
EP2603098A4
(en)
|
2010-08-12 |
2018-01-17 |
Senomyx, Inc. |
Method of improving stability of sweet enhancer and composition containing stabilized sweet enhancer
|
US20120321590A1
(en)
|
2011-04-06 |
2012-12-20 |
Anadys Pharmaceuticals, Inc. |
Bridged polycyclic compounds
|
AU2012288900B2
(en)
|
2011-07-27 |
2016-10-06 |
Ab Science |
Selective protein kinase inhibitors
|
US8664247B2
(en)
|
2011-08-26 |
2014-03-04 |
Radiorx, Inc. |
Acyclic organonitro compounds for use in treating cancer
|
WO2013052164A1
(en)
|
2011-10-07 |
2013-04-11 |
Radiorx, Inc. |
Organonitro thioether compounds and medical uses thereof
|
WO2013052803A2
(en)
|
2011-10-07 |
2013-04-11 |
Radiorx, Inc. |
Methods and compositions comprising a nitrite-reductase promoter for treatment of medical disorders and preservation of blood products
|
JP2015507635A
(ja)
|
2011-12-30 |
2015-03-12 |
レビバ ファーマシューティカルズ,インコーポレイティド |
組成物、合成およびフェニルシクロアルキルメチルアミン誘導体を使用する方法
|
EP3593648B1
(en)
|
2012-08-06 |
2021-07-14 |
Firmenich Incorporated |
Sweet flavor modifier
|
JO3155B1
(ar)
|
2013-02-19 |
2017-09-20 |
Senomyx Inc |
معدِّل نكهة حلوة
|
EP2970188A4
(en)
|
2013-03-15 |
2016-10-19 |
Vm Therapeutics Llc |
NOVEL CRYSTALLINE FORMS
|
US8999992B2
(en)
|
2013-03-15 |
2015-04-07 |
Vm Pharma Llc |
Crystalline forms of tryosine kinase inhibitors and their salts
|
JP2016517883A
(ja)
|
2013-05-03 |
2016-06-20 |
オレゴン ヘルス アンド サイエンス ユニバーシティー |
X連鎖副腎白質ジストロフィーの処置におけるソベチロムの使用
|
WO2014195032A1
(en)
|
2013-06-07 |
2014-12-11 |
Medical Prognosis Institute A/S |
Methods and devices for predicting treatment efficacy of fulvestrant in cancer patients
|
SI3102555T1
(sl)
|
2014-02-05 |
2021-11-30 |
VM Oncology LLC |
Sestavki spojin in njihove uporabe
|
CN106170488B
(zh)
|
2014-02-12 |
2020-09-18 |
弗门尼舍公司 |
用于取代的1-苄基-3-(1-(异噁唑-4-基甲基)-1h-吡唑-4-基)咪唑烷-2,4-二酮的合成的改进方法
|
CN106414433A
(zh)
|
2014-03-24 |
2017-02-15 |
Ab科学有限公司 |
作为脾酪氨酸激酶抑制剂的二氮杂螺烷酮取代的噁唑衍生物
|
GB2525626A
(en)
*
|
2014-04-29 |
2015-11-04 |
Alexander Francois Robert Templet |
Composition and method for inhalable nutritional element
|
US10336768B2
(en)
|
2014-06-13 |
2019-07-02 |
Yuma Therapeutics, Inc. |
Pyrimidine compounds and methods using the same
|
CA2957250A1
(en)
|
2014-08-15 |
2016-02-18 |
Adynxx, Inc. |
Oligonucleotide decoys for the treatment of pain
|
CA2962206A1
(en)
|
2014-09-17 |
2016-03-24 |
Mundipharma International Corporation Limited |
Crystalline forms of tyrosine kinase inhibitors and their salts
|
WO2016115144A1
(en)
|
2015-01-12 |
2016-07-21 |
Reviva Pharmaceuticals Inc. |
Methods for treating alzheimer's disease
|
CN107206007B
(zh)
|
2015-01-12 |
2021-08-10 |
雷维瓦药品公司 |
用于治疗肺高血压的方法
|
ES2796276T3
(es)
|
2015-02-05 |
2020-11-26 |
Ab Science |
Compuestos con actividad antitumoral
|
EP3144307A1
(en)
|
2015-09-18 |
2017-03-22 |
AB Science |
Novel oxazole derivatives that inhibit syk
|
EP3355885A4
(en)
|
2015-10-01 |
2019-04-24 |
Elysium Therapeutics, Inc. |
MULTI-SUBUNIT OPIOID PRODRUGS WITH RESISTANCE TO OVERDOSE AND MISUSE
|
US10335406B2
(en)
|
2015-10-01 |
2019-07-02 |
Elysium Therapeutics, Inc. |
Opioid compositions resistant to overdose and abuse
|
CN108473484B
(zh)
|
2015-10-01 |
2021-06-29 |
弗门尼舍公司 |
可用作trpm8调节剂的化合物
|
US10342778B1
(en)
|
2015-10-20 |
2019-07-09 |
Epicentrx, Inc. |
Treatment of brain metastases using organonitro compound combination therapy
|
US9987270B1
(en)
|
2015-10-29 |
2018-06-05 |
Epicentrix, Inc. |
Treatment of gliomas using organonitro compound combination therapy
|
EA201891606A1
(ru)
|
2016-01-11 |
2019-02-28 |
Эписентарикс, Инк. |
Композиции и способы для внутривенного введения 2-бром-1-(3,3-динитроазетидин-1-ил)этанона
|
EA201990949A1
(ru)
|
2016-10-14 |
2019-10-31 |
|
Сульфоксиалкильные органические нитросоединения и родственные соединения и фармацевтические композиции для применения в медицине
|
WO2018152509A1
(en)
|
2017-02-20 |
2018-08-23 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Hydrogen sulfide and/or nitrite in the treatment and prevention of atrial fibrillation
|
JP7234130B2
(ja)
|
2017-03-17 |
2023-03-07 |
エリージウム セラピューティクス, インコーポレイテッド |
過剰摂取および乱用に対して抵抗性のポリサブユニットオピオイドプロドラッグ
|
SG11201910198UA
(en)
|
2017-06-05 |
2019-11-28 |
Flagship Pioneering Innovations V Inc |
Multibiotic agents and methods of using the same
|
JP7377791B2
(ja)
|
2017-07-07 |
2023-11-10 |
エピセントアールエックス,インコーポレイテッド |
治療剤の非経口投与のための組成物
|
US11510901B2
(en)
|
2018-01-08 |
2022-11-29 |
Epicentrx, Inc. |
Methods and compositions utilizing RRx-001 combination therapy for radioprotection
|
EP3773614A1
(en)
|
2018-04-12 |
2021-02-17 |
Matrx Therapeutics Corporation |
Compositions and methods for treating elastic fiber breakdown
|
EP4227293A3
(en)
|
2018-05-14 |
2023-10-04 |
Xgene Pharmaceutical Inc |
Crystalline forms of 1-(acyloxy)-alkyl carbamate drug conjugates of naproxen and pregabalin
|
WO2020033420A1
(en)
|
2018-08-07 |
2020-02-13 |
Firmenich Incorporated |
5-substituted 4-amino-1h-benzo[c][1,2,6]thiadiazine 2,2-dioxides and formulations and uses thereof
|
EP4058456A1
(en)
|
2019-11-13 |
2022-09-21 |
RAPT Therapeutics, Inc. |
Crystalline forms of c-c chemokine receptor type 4 antagonist and uses thereof
|
JP2023528404A
(ja)
*
|
2020-06-01 |
2023-07-04 |
アドベント セラピューティクス インコーポレイテッド |
不溶性活性成分を含む医薬組成物
|
WO2021247963A1
(en)
|
2020-06-05 |
2021-12-09 |
Senda Biosciences, Inc. |
(s)-alpha-fluoromethyltyrosine as decarboxylase inhibitors for use in the treatment of hypotension
|
WO2023172415A1
(en)
|
2022-03-07 |
2023-09-14 |
Firmenich Incorporated |
Sweetener compositions
|
WO2023169995A1
(en)
|
2022-03-10 |
2023-09-14 |
Firmenich Sa |
Sweetener compositions
|
WO2023178283A1
(en)
|
2022-03-18 |
2023-09-21 |
Epicentrx, Inc. |
Co-crystals of 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethanone and methods
|
WO2023198436A2
(en)
|
2022-04-11 |
2023-10-19 |
Firmenich Sa |
Sweetener compositions
|
WO2024044770A1
(en)
|
2022-08-26 |
2024-02-29 |
Core Biotherapeutics, Inc. |
Oligonucleotides for the treatment of breast cancer
|